[e-drug] Cardiovascular Guidelines Ed 4

["Enid Meldrum" <emeldrum@tg.com.au>]

E-drug: Cardiovascular Guidelines Ed 4
---------------------------------------------

'Therapeutic Guidelines Ltd' released the 4th edition of 
Cardiovascular Guidelines in August: Therapeutic Guidelines 
Cardiovascular 4.  

Major revisions in this new edition cover:
? Primary and secondary prevention of atheromatous disease
? A list of cardiovascular risk assessment tools
? An increased emphasis on preventing and dealing with the decline of 
renal function (with or without diabetes)
? Treatment of heart failure, with the emphasis on improving prognosis
?  Coronary pain syndromes including newer drugs for managing the 
acute phase and the increasing use of early revascularisation for 
high-risk patients
? Pre-eclampsia including the significant therapeutic findings from a 
recent large study
? Uncomplicated benign hypertension - endorsement from a review of 
trial evidence for diuretics as the most cost-effective initial 
treatment
? Assessment and treatment of smoking

Also:
? Updated information on dyslipidaemia; hypertension; hypertension 
and cardiovascular disease in pregnancy; arrhythmias; peripheral 
vascular and cerebrovascular disease; venous thrombosis and pulmonary 
embolism
? Appendices on cardiovascular drug interactions, etc.

'Therapeutic Guidelines Ltd'  is an Australian not for profit 
organisation that has become well known internationally, particularly 
for the production of Antibiotic, Psychotropic and Analgesic 
guidelines as well as a range of other titles.  These guidelines are 
independent, peer reviewed and regularly updated.  Sales of products 
sustain the continuation of the organisation and development of more 
guidelines.  There is no sponsorship!

More details can be found at
http://www.tg.com.au

For more information contact
Enid Meldrum
Therapeutic Guidelines Limited
2/55 Flemington Rd.,
North Melbourne.  Vic   Australia 3051
Ph 61 3 9329 6427
<emeldrum@tg.com.au>

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug